Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-07-17 EDT			5-day change	1st Jan Change
2,455.05 ^INR	-2.06%		+0.80%	-0.64%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.41B	-	-	-		-
ELI LILLY AND COMPANY	1,043B		A
JOHNSON & JOHNSON	602B		BBB
ABBVIE INC.	449B		AA	-
ROCHE HOLDING AG	327B		AA
NOVARTIS AG	279B		AAA
ASTRAZENECA PLC	264B		A
AMGEN INC.	201B		A
GILEAD SCIENCES, INC.	169B		AA
PFIZER INC.	143B		A
VERTEX PHARMACEUTICALS INCORPORATED	123B		AA
BRISTOL-MYERS SQUIBB COMPANY	124B		A
SANOFI	106B		AA
GSK PLC	105B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	73.36B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	54.49B		AA
BAYER AG	53.63B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	51.98B		AA
HALEON PLC	43.95B		AA
Average	214.01B		AA
Weighted average by Cap.			AA